Form 4: STERIS Executive Cary Majors Reports Equity Transactions

Cary L. Majors, SVP and President of Healthcare at STERIS plc, reported the acquisition of restricted shares and stock options.

Summary

• Cary L. Majors acquired 4,746 ordinary shares on June 2, 2026.
• 67 shares were withheld for tax obligations related to the vesting of restricted shares at a price of $209.76 per share.
• The reporting person was granted 16,548 employee stock options with an exercise price of $230.74.
• Following these transactions, the reporting person holds 17,338 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding executive compensation and ownership changes, which carries a neutral sentiment.

Positives

• The acquisition of equity and options aligns the executive's interests with long-term shareholder value.
• The vesting schedule for restricted shares and options encourages long-term retention of key leadership.

Negatives

• The transaction involved a tax-related share withholding, which is a standard but routine reduction in total holdings.

Risks

• The value of the granted stock options is dependent on the future market performance of STERIS plc shares exceeding the $230.74 exercise price.

Future Outlook

The filing outlines a multi-year vesting schedule for restricted shares through June 2029 and stock options through June 2030, indicating long-term commitment to the company.

Industry Context

StockSavvy.ai notes that equity grants for senior executives in the medical technology sector are standard practice to ensure leadership alignment with long-term strategic growth and shareholder interests.

Comparison to Industry Standards

• The use of restricted stock units and stock options is consistent with compensation structures at peer companies like Baxter International and Becton Dickinson.
• The vesting periods of 3-4 years align with standard corporate governance practices for executive retention.

Stakeholder Impact

• Shareholders may view the long-term vesting schedule as a positive indicator of management stability.

Next Steps

• Vesting of restricted shares on June 4, 2027.
• Exercisability of first tranche of stock options on June 2, 2027.

Key Dates

Keywords

STERIS, STE, Form 4, Insider Trading, Equity Compensation, Healthcare